The export performance of two out of three pharmaceutical and biotech companies is reported to have increased year-over-year (YoY). The total export sales of 24 companies increased from KRW 3.6869 trillion to KRW 4.8975 trillion over the year, up 33%.

In particular, the export performance of Samsung Biologics, Celltrion, and SK Biopharmaceuticals has substantially improved. Samsung Biologics' export sales increased by over KRW 500 billion over the year, recording over KRW 2 trillion in export sales in the first half of the year. Export sales of Celltrion and SK Biopharmaceuticals increased by over 50% YoY.

Export sales↑in 17 out of 24 listed pharmaceutical companies…Celltrio

Kim, Jin-Gu(kjg@dailypharm.com)